azacitidine has been researched along with Burkitt Lymphoma in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (11.11) | 18.7374 |
| 1990's | 10 (37.04) | 18.2507 |
| 2000's | 8 (29.63) | 29.6817 |
| 2010's | 4 (14.81) | 24.3611 |
| 2020's | 2 (7.41) | 2.80 |
| Authors | Studies |
|---|---|
| Georgieva, SG; Ilyin, YV; Kotnova, AP; Pankratova, EV; Stepchenko, AG | 1 |
| de Graaf, IJ; Heemskerk, MHM; Kroonen, JS; Kumar, S; Remst, DFG; Vertegaal, ACO; Wouters, AK | 1 |
| Cho, SG; Dong, SM; Hayward, SD; Kim, H; Kwon, HJ; Kwon, SH; Lee, HG; Lee, JH; Lee, JM; Park, JH; Park, PG; Yoon, H | 1 |
| Apa, AG; Arruda, VO; de Rezende, LM; Klumb, CE; Mazzoccoli, L; Reis, FR; Robaina, MC | 1 |
| Cui, MY; Gao, XZ; Li, WC; Wang, GN; Zhang, YR; Zhao, WG | 1 |
| Cleveland, JL; Garrison, SP; Hall, MA; Jeffers, JR; Nilsson, JA; Onciu, M; Rehg, JE; Sample, JT; Yang, C; Yu, J; Yue, W; Zambetti, GP; Zhang, L | 1 |
| Forshell, LP; Höglund, A; Maclean, KH; Nilsson, JA; Nilsson, LM | 1 |
| Guan, H; Klapproth, K; Ushmorov, A; Weitzer, CD; Wirth, T; Xie, L | 1 |
| Hummel, M; Leithäuser, F; Möller, P; Ritz, O; Stein, H; Ushmorov, A; Wirth, T | 1 |
| Berger, C; Bernasconi, M; Nadal, D; Rao, SP; Rechsteiner, MP; Sigrist, JA | 1 |
| Akao, Y; Kinoshita, T; Kitade, Y; Nakagawa, Y; Naoe, T | 1 |
| Ben-Sasson, SA; Klein, G | 1 |
| Brouet, JC; Dellagi, K; Lenoir, GM; Portier, MM | 1 |
| Farrell, PJ; Holder, A; Palmero, I; Peters, G; Sinclair, AJ | 1 |
| Ambinder, RF; Barletta, J; Robertson, KD; Samid, D | 1 |
| Cuomo, L; de Campos-Lima, PO; Klein, G; Masucci, MG; Ragnar, E; Trivedi, P; Zhang, QJ | 1 |
| Klein, E; Kuraya, M; Minarovits, J; Okada, H | 1 |
| Ehrlich, M; Frady, A; Hernandez, R; Ji, W; Qu, GZ; Varela, M; Zhang, XY | 1 |
| Baylin, SB; Herman, JG; Katzenellenbogen, RA | 1 |
| Flemington, EK; Jung, EJ; Rodriguez, A | 1 |
| Caron, M; Joubert-Caron, R; Labas, V; le Caër, JP; Poirier, F; Pontet, M; Raphaël, M; Sghiouar-Imam, N | 1 |
| Biesta, P; Quinten, E; van den Elsen, PJ; van der Stoep, N | 1 |
| Jansson, A; Masucci, M; Rymo, L | 1 |
| Altiok, E; Contreras-Brodin, B; Ernberg, I; Hu, LF; Klein, G; Minarovits, J | 1 |
| Klein, E; Klein, G; Kuraya, M; Yefenof, E | 1 |
| Schaefer, BC; Speck, SH; Strominger, JL; Woisetschlaeger, M | 1 |
| Contreras-Salazar, B; Ernberg, I; Falk, K; Klein, G; Masucci, MG; Minarovits, J; Ragnar, E | 1 |
27 other study(ies) available for azacitidine and Burkitt Lymphoma
| Article | Year |
|---|---|
5-Azacytidine Suppresses the Expression of Tissue-Specific Oct-1 Isoform in Namalwa Burkitt's Lymphoma Cell Culture.
Topics: Animals; Azacitidine; Burkitt Lymphoma; Cell Culture Techniques; Leukemia; Mice; Octamer Transcription Factor-1; Protein Isoforms; RNA, Messenger; Tumor Cells, Cultured | 2022 |
Inhibition of SUMOylation enhances DNA hypomethylating drug efficacy to reduce outgrowth of hematopoietic malignancies.
Topics: Azacitidine; Burkitt Lymphoma; Cell Line, Tumor; Decitabine; DNA; Hematologic Neoplasms; Humans; Lymphoma, Large B-Cell, Diffuse; Sumoylation | 2023 |
Hypermethylation of the interferon regulatory factor 5 promoter in Epstein-Barr virus-associated gastric carcinoma.
Topics: Azacitidine; Burkitt Lymphoma; Cell Line, Tumor; CpG Islands; Decitabine; DNA Methylation; Epigenesis, Genetic; Herpesvirus 4, Human; Humans; Interferon Regulatory Factors; Promoter Regions, Genetic; Sequence Analysis, DNA; Stomach Neoplasms; Virus Latency | 2015 |
Deregulation of DNMT1, DNMT3B and miR-29s in Burkitt lymphoma suggests novel contribution for disease pathogenesis.
Topics: Adolescent; Azacitidine; Burkitt Lymphoma; Cell Line, Tumor; Child; Child, Preschool; Cyclin-Dependent Kinase Inhibitor p16; Cytidine Triphosphate; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3B; Female; Gene Expression Regulation, Neoplastic; Humans; Male; MicroRNAs; Promoter Regions, Genetic; RNA, Messenger | 2015 |
Inhibitor of DNA binding 4 functions as a tumor suppressor and is targetable by 5-aza-2'-deoxycytosine with potential therapeutic significance in Burkitt's lymphoma.
Topics: Apoptosis; Azacitidine; Burkitt Lymphoma; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Decitabine; DNA Methylation; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, Tumor Suppressor; Humans; Inhibitor of Differentiation Proteins; Promoter Regions, Genetic | 2016 |
Selection against PUMA gene expression in Myc-driven B-cell lymphomagenesis.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Azacitidine; B-Lymphocytes; Base Sequence; Burkitt Lymphoma; Cell Line, Tumor; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histones; Humans; Methylation; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2008 |
Myc sensitizes p53-deficient cancer cells to the DNA-damaging effects of the DNA methyltransferase inhibitor decitabine.
Topics: Aneuploidy; Animals; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Blotting, Western; Burkitt Lymphoma; Cell Cycle; Decitabine; DNA Damage; DNA Methylation; DNA Modification Methylases; DNA, Neoplasm; Embryo, Mammalian; Epstein-Barr Virus Infections; Fibroblasts; Herpesvirus 4, Human; Humans; Kidney; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Mutation; Proto-Oncogene Proteins c-myc; Tumor Suppressor Protein p53 | 2009 |
Decitabine represses translocated MYC oncogene in Burkitt lymphoma.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Burkitt Lymphoma; Cell Line, Tumor; Cell Proliferation; Decitabine; DNA Modification Methylases; Dose-Response Relationship, Drug; Epigenetic Repression; Gene Expression Regulation, Neoplastic; Humans; Immunoglobulin M; Inhibitor of Differentiation Protein 2; NF-kappa B; Proto-Oncogene Proteins c-myc; Transcription, Genetic; Transfection; Translocation, Genetic; Up-Regulation | 2013 |
Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Burkitt Lymphoma; Cell Line, Tumor; Decitabine; DNA Methylation; Down-Regulation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Gene Silencing; Hodgkin Disease; Humans; Immunoglobulin Heavy Chains; Octamer Transcription Factor-2; Promoter Regions, Genetic; Trans-Activators; Transcription Factors; Transcription, Genetic | 2004 |
Zebularine reactivates silenced E-cadherin but unlike 5-Azacytidine does not induce switching from latent to lytic Epstein-Barr virus infection in Burkitt's lymphoma Akata cells.
Topics: Antineoplastic Agents; Azacitidine; Burkitt Lymphoma; Cadherins; Cytidine; Gene Silencing; Herpesvirus 4, Human; Humans; Tumor Cells, Cultured; Virus Latency | 2007 |
Downregulation of microRNAs-143 and -145 in B-cell malignancies.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Burkitt Lymphoma; Cell Line, Tumor; Cell Survival; Decitabine; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Leukemia, Lymphocytic, Chronic, B-Cell; Lymph Nodes; Lymphoma, B-Cell; MicroRNAs; RNA, Neoplasm; Tumor Cells, Cultured | 2007 |
Activation of the Epstein-Barr virus genome by 5-aza-cytidine in latently infected human lymphoid lines.
Topics: Antigens, Viral; Azacitidine; Burkitt Lymphoma; Cell Line; Dose-Response Relationship, Drug; Genes, Viral; Herpesvirus 4, Human; Humans; Idoxuridine; Time Factors; Virus Activation | 1981 |
Abnormal expression of vimentin intermediate filaments in human lymphoid cell lines with deletion or translocation of the distal end of chromosome 8.
Topics: Azacitidine; Burkitt Lymphoma; Cell Line; Chromosome Deletion; Chromosomes, Human, 6-12 and X; Fluorescent Antibody Technique; Humans; Intermediate Filament Proteins; Lymphocytes; Translocation, Genetic; Vimentin | 1984 |
Expression of cyclin D2 in Epstein-Barr virus-positive Burkitt's lymphoma cell lines is related to methylation status of the gene.
Topics: Antigens, Viral; Azacitidine; Base Sequence; Burkitt Lymphoma; Cyclin D2; Cyclins; DNA-Binding Proteins; Epstein-Barr Virus Nuclear Antigens; Gene Expression Regulation; Herpesvirus 4, Human; Humans; Methylation; Molecular Sequence Data; Tumor Cells, Cultured | 1995 |
Pharmacologic activation of expression of immunodominant viral antigens: a new strategy for the treatment of Epstein-Barr-virus-associated malignancies.
Topics: Adult; Antigens, Viral; Azacitidine; Base Sequence; Burkitt Lymphoma; Decitabine; DNA-Binding Proteins; DNA, Neoplasm; DNA, Viral; Epstein-Barr Virus Nuclear Antigens; Gene Expression Regulation, Viral; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Immunodominant Epitopes; Lymphoma, B-Cell; Methylation; Molecular Sequence Data; Polymerase Chain Reaction; Tumor Cells, Cultured; Tumor Virus Infections; Viral Matrix Proteins; Virus Activation | 1995 |
Selective induction of allostimulatory capacity after 5-azaC treatment of EBV carrying but not EBV negative Burkitt lymphoma cell lines.
Topics: Antigens, CD; Antigens, Surface; Antigens, Viral; Azacitidine; B-Lymphocytes; Biomarkers; Burkitt Lymphoma; Cell Line, Transformed; Cell Transformation, Viral; DNA-Binding Proteins; Electrophoresis, Polyacrylamide Gel; Epstein-Barr Virus Nuclear Antigens; Herpesvirus 4, Human; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Immunization; Immunoblotting; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Membrane Proteins; Time Factors; Transfection; Tumor Cells, Cultured; Viral Matrix Proteins | 1993 |
HRF20/CD59 complement regulatory protein expression is phenotype-dependent and inducible by the hypomethylating agent 5-azacytidine on Burkitt's lymphoma cell lines.
Topics: Antigens, CD; Azacitidine; B-Lymphocytes; Burkitt Lymphoma; CD59 Antigens; Cell Line, Transformed; DNA, Neoplasm; Gene Expression; Herpesvirus 4, Human; Humans; Immunophenotyping; Lymphocyte Activation; Membrane Glycoproteins; Methylation; Tumor Cells, Cultured; Up-Regulation | 1993 |
DNA demethylation and pericentromeric rearrangements of chromosome 1.
Topics: Adult; Azacitidine; B-Lymphocytes; Burkitt Lymphoma; Cell Line; Cell Line, Transformed; Centromere; Chromosome Aberrations; Chromosome Disorders; Chromosomes, Human, Pair 1; Decitabine; DNA Methylation; DNA, Satellite; Face; Fibroblasts; Heterochromatin; Humans; Immunologic Deficiency Syndromes; Male; Stem Cells; Tumor Cells, Cultured | 1997 |
Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Azacitidine; Burkitt Lymphoma; Calcium-Calmodulin-Dependent Protein Kinases; CpG Islands; Death-Associated Protein Kinases; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Humans; Interferon-gamma; Leukemia; Lymphocytes; Lymphoma, T-Cell; Tumor Cells, Cultured | 1999 |
Cell cycle analysis of Epstein-Barr virus-infected cells following treatment with lytic cycle-inducing agents.
Topics: Azacitidine; Burkitt Lymphoma; Cell Cycle; Cell Line; DNA-Binding Proteins; Herpesvirus 4, Human; Humans; Idoxuridine; Tetradecanoylphorbol Acetate; Trans-Activators; Tumor Cells, Cultured; Viral Proteins | 2001 |
Two-dimensional database of a Burkitt lymphoma cell line (DG 75) proteins: protein pattern changes following treatment with 5'-azycytidine.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Burkitt Lymphoma; Databases, Factual; Electrophoresis, Gel, Two-Dimensional; Humans; Neoplasm Proteins; Tumor Cells, Cultured | 2001 |
Lack of IFN-gamma-mediated induction of the class II transactivator (CIITA) through promoter methylation is predominantly found in developmental tumor cell lines.
Topics: Azacitidine; Burkitt Lymphoma; Carcinoma; Cell Differentiation; CpG Islands; DNA Methylation; Gene Expression Regulation, Developmental; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, MHC Class II; Genes, Reporter; HLA-DR Antigens; Humans; Interferon-gamma; Melanoma; Neoplasm Proteins; Nuclear Proteins; Promoter Regions, Genetic; Signal Transduction; Trans-Activators; Transfection; Tumor Cells, Cultured | 2002 |
Methylation of discrete sites within the enhancer region regulates the activity of the Epstein-Barr virus BamHI W promoter in Burkitt lymphoma lines.
Topics: Antigens, Viral; Azacitidine; Base Sequence; Burkitt Lymphoma; Deoxyribonuclease BamHI; DNA, Recombinant; DNA, Viral; Enhancer Elements, Genetic; Epstein-Barr Virus Nuclear Antigens; Gene Expression Regulation, Viral; Herpesvirus 4, Human; Methylation; Molecular Sequence Data; Promoter Regions, Genetic; Restriction Mapping; Transfection; Tumor Cells, Cultured | 1992 |
Host-cell-phenotype-dependent control of the BCR2/BWR1 promoter complex regulates the expression of Epstein-Barr virus nuclear antigens 2-6.
Topics: Antigens, Viral; Azacitidine; B-Lymphocytes; Base Sequence; Burkitt Lymphoma; DNA; Epstein-Barr Virus Nuclear Antigens; Gene Expression Regulation, Viral; Herpesvirus 4, Human; In Vitro Techniques; Methylation; Molecular Sequence Data; Nasopharyngeal Neoplasms; Oligodeoxyribonucleotides; Promoter Regions, Genetic; Regulatory Sequences, Nucleic Acid; RNA, Messenger; RNA, Viral | 1992 |
Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis.
Topics: Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, B-Lymphocyte; Azacitidine; Blood; Burkitt Lymphoma; CD55 Antigens; CD59 Antigens; Complement C3; Cytotoxicity, Immunologic; Humans; Interferon-gamma; Membrane Glycoproteins; Membrane Proteins; Receptors, Complement; Receptors, Complement 3d; Tumor Necrosis Factor-alpha | 1992 |
Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
Topics: Animals; Antigens, Viral; Azacitidine; Base Sequence; Burkitt Lymphoma; Cell Line; Cloning, Molecular; Epstein-Barr Virus Nuclear Antigens; Exons; Herpesvirus 4, Human; Humans; Lymphocytes; Molecular Sequence Data; Oligonucleotide Probes; Polymerase Chain Reaction; Promoter Regions, Genetic; Rats; Restriction Mapping; RNA, Neoplasm; RNA, Viral; Transcription, Genetic | 1991 |
5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael.
Topics: Antigens, Viral; Azacitidine; Burkitt Lymphoma; Capsid; Cell Line; Epstein-Barr Virus Nuclear Antigens; Fluorescent Antibody Technique; Gene Expression Regulation; Genes; Genes, Viral; Herpesvirus 4, Human; Humans; Immunoblotting; Kinetics; Methylation; Viral Matrix Proteins | 1989 |